{
    "clinical_study": {
        "@rank": "58758", 
        "acronym": "ABSORB UK", 
        "arm_group": {
            "arm_group_label": "Absorb BVS", 
            "description": "Subjects receiving Absorb BVS"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the safety and clinical outcomes of the Absorb BVS\n      for daily use in patients with de novo lesions in previously untreated vessels."
        }, 
        "brief_title": "To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels", 
        "completion_date": {
            "#text": "November 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Coronary Disease", 
            "Coronary Artery Disease", 
            "Coronary Restenosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Coronary Restenosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "ABSORB UK registry is a prospective, single arm, post-market registry designed to:\n\n        -  Provide ongoing post-market surveillance for documentation of safety and clinical\n           outcomes of the Absorb Everolimus Eluting BVS System in daily percutaneous coronary\n           intervention (PCI) practice per Instructions for Use (IFU, on-label use).\n\n        -  Collect additional information (e.g. acute success) to evaluate handling and\n           implantation of Absorb BVS by physicians under a wide range of commercial use\n           conditions and following routine clinical practice."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        The inclusion criteria must follow the most recent IFU which may include but are not\n        limited to the following:\n\n          -  Patient must be at least 18 years of age at the time of signing the Informed Consent\n             Form\n\n          -  Patient is to be treated for de novo lesions located in previously untreated vessels.\n\n          -  Patient must agree to undergo all required follow-up visits and data collection.\n\n        Exclusion Criteria:\n\n        The exclusion criteria must follow the most recent IFU which may include but are not\n        limited to the following:\n\n          -  Inability to obtain a signed informed consent from potential patient.\n\n          -  Patient belongs to a vulnerable population (per investigator's judgment, this also\n             includes people with a direct link (hierarchical or financial benefit) to the\n             registry Doctor or the registry Sponsor)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients will be selected from the general interventional cardiology population"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01977534", 
            "org_study_id": "13-304"
        }, 
        "intervention": {
            "arm_group_label": "Absorb BVS", 
            "description": "The Absorb BVS System is a bioresorbable poly(L-lactide) (PLLA) scaffold with a drug and bioresorbable polymer coating [formulation of everolimus in a bioresorbable poly(D,L-lactide) (PDLLA) coating].", 
            "intervention_name": "Absorb BVS", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Bioabsorbable", 
            "Coronary Stent", 
            "Everolimus", 
            "drug eluting stents", 
            "stents", 
            "angioplasty", 
            "coronary artery disease", 
            "total coronary occlusion", 
            "coronary artery restenosis", 
            "stent thrombosis", 
            "vascular disease", 
            "myocardial ischemia", 
            "coronary artery stenosis", 
            "CAD", 
            "CAOD"
        ], 
        "lastchanged_date": "December 2, 2013", 
        "number_of_groups": "1", 
        "official_title": "A Post-market Registry of Patients With de Novo Lesions in Previously Untreated Vessels Treated With Absorb BVS", 
        "other_outcome": {
            "description": "Access site (femoral, brachial, radial)\nLesion preparation (Lesion 1, 2, 3, etc.)\nBalloon pre-dilatation (yes - Max balloon size/Max balloon pressure, Cutting balloon yes/no, Other yes/no)\nTechniques used to adequately prepare the lesion (de-calcification techniques (Rotablator yes/no, Other yes/no))\nTreatment parameters\nCASS numbers\nNo. of scaffolds per analyzable lesion (Lesion 1, 2, 3, etc.)\nScaffold length (Lesion 1, Lesion 2, Lesion 3, etc.)\nLesion length (Lesion 1, Lesion 2, Lesion 3, etc.)\nBailout / bailout device (if bailout required)\nPost-treatment of lesion?\nBalloon post-dilatation (no, yes - Max balloon diameter/Max balloon pressures/balloon length)\nJailed side-branch (no, yes). If yes, treatment of jailed sidebranch? (no, yes)", 
            "measure": "Acute Procedural Analyses (all patients)", 
            "safety_issue": "Yes", 
            "time_frame": "During the implantation procedure"
        }, 
        "overall_contact": {
            "email": "kathleen.peeters@av.abbott.com", 
            "last_name": "Kathleen Peeters", 
            "phone": "32-2-4169399"
        }, 
        "overall_official": [
            {
                "affiliation": "Bristol Heart institute", 
                "last_name": "Andreas Baumbach", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Abbott Vascular", 
                "last_name": "Peter Staehr, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Clinical Science", 
                "last_name": "Susan Veldhof", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Achievement of a final in-scaffold residual diameter stenosis of < 50% assessed by online quantitative angiography or visual estimation, using Absorb BVS and without a device deficiency. A device is considered to have failed if it did not meet the requirements of the definition for clinical device success.", 
                "measure": "Acute Success: Device success (lesion based analysis)", 
                "safety_issue": "Yes", 
                "time_frame": "From the start of index procedure to end of index procedure"
            }, 
            {
                "description": "Achievement of a final in-scaffold diameter stenosis of < 50% by online QCA or visual estimation using Absorb BVS, with or without any adjunctive devices, and without the occurrence of cardiac death, target vessel MI (Q-wave and non Q-wave MI), or repeat revascularization of the target lesion within 3 days of the index procedure.", 
                "measure": "Acute Success: Procedural success (patient based analysis)", 
                "safety_issue": "Yes", 
                "time_frame": "From the start of index procedure to end of index procedure"
            }, 
            {
                "measure": "Death (Cardiovascular, Non-Cardiovascular)", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Death (Cardiovascular, Non-Cardiovascular)", 
                "safety_issue": "Yes", 
                "time_frame": "3 year"
            }, 
            {
                "description": "Attributable to Q-wave MI (QMI), non-Q wave MI (NQMI), target vessel (TV), non-target vessel (NTV)", 
                "measure": "Myocardial Infarction (MI)", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Attributable to Q-wave MI (QMI), non-Q wave MI (NQMI), target vessel (TV), non-target vessel (NTV)", 
                "measure": "MI", 
                "safety_issue": "Yes", 
                "time_frame": "3 year"
            }, 
            {
                "description": "all TLR", 
                "measure": "Target Lesion Revascularization (TLR)", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "description": "all TLR", 
                "measure": "TLR", 
                "safety_issue": "Yes", 
                "time_frame": "3 year"
            }, 
            {
                "description": "clinically indicated (ID-TLR)", 
                "measure": "TLR", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "description": "ID-TLR", 
                "measure": "TLR", 
                "safety_issue": "Yes", 
                "time_frame": "3 year"
            }, 
            {
                "description": "all TVR", 
                "measure": "Target Vessel Revascularization (TVR)", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "description": "all TVR", 
                "measure": "TVR", 
                "safety_issue": "Yes", 
                "time_frame": "3 year"
            }, 
            {
                "description": "clinically indicated (ID-TVR)", 
                "measure": "TVR", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "description": "ID-TVR", 
                "measure": "TVR", 
                "safety_issue": "Yes", 
                "time_frame": "3 year"
            }, 
            {
                "measure": "Cardiac Death/TV-MI/ID-TLR (Target Lesion Failure (TLF)) (Device-oriented endpoint)", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Cardiac Death/TV-MI/ID-TLR (Target Lesion Failure (TLF)) (Device-oriented endpoint)", 
                "safety_issue": "Yes", 
                "time_frame": "3 year"
            }, 
            {
                "measure": "Cardiac Death/All MI/ID-TLR (MACE)", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Cardiac Death/All MI/ID-TLR (MACE)", 
                "safety_issue": "Yes", 
                "time_frame": "3 year"
            }, 
            {
                "measure": "Cardiac Death/All MI/ID-TVR (Target Vessel Failure (TVF))", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Cardiac Death/All MI/ID-TVR (Target Vessel Failure (TVF))", 
                "safety_issue": "Yes", 
                "time_frame": "3 year"
            }, 
            {
                "description": "acute, sub-acute, late and very late", 
                "measure": "Scaffold/Stent Thrombosis", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Definite, Probable", 
                "measure": "Scaffold/Stent Thrombosis", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "description": "acute, sub-acute, late and very late", 
                "measure": "Scaffold/Stent Thrombosis", 
                "safety_issue": "Yes", 
                "time_frame": "3 year"
            }, 
            {
                "description": "Definite, Probable", 
                "measure": "Scaffold/Stent Thrombosis", 
                "safety_issue": "Yes", 
                "time_frame": "3 year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01977534"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Abbott Vascular", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abbott Vascular", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "3 Years", 
        "verification_date": "December 2013"
    }
}